Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and...
19 insider purchases on record · latest filing 2025-05-14.
Insiders have also filed 168 sale transactions at HOWL.